Defta Partners
Overview
DEFTA Partners is a global venture capital firm founded in the 1980s, with offices in San Francisco, Tokyo, and Hong Kong. The firm specializes in early-stage investments in technology companies, particularly in the healthcare and information and communication technology (ICT) sectors. DEFTA Partners has a history of identifying, nurturing, and funding companies with innovative technologies across North America, Europe, Asia, and the Middle East. The firm's investment strategy focuses on sectors such as biotechnology, medical devices, healthcare IT, and ICT. DEFTA Partners invests in companies developing advanced therapeutics, health ICT, and enabling technologies. The firm has a global investment approach, having invested in over 100 companies across various regions, including the United States, United Kingdom, Israel, Bangladesh, and Japan. DEFTA Partners aims to enable sustainable growth and scale its portfolio companies internationally. DEFTA Partners has a track record of successful investments in early-stage technology companies. Notable investments include Aegle Therapeutics, Actuate Therapeutics, and QuantuMDx. The firm's founder, George Hara, has been instrumental in leading and funding numerous companies to success, including Viagene, Isis Pharmaceuticals, and Arris Pharmaceuticals. DEFTA Partners continues to focus on identifying and supporting transformative solutions that address pressing healthcare challenges and enhance patient outcomes.
Investment Focus
- Companies in early stages of development
- Innovative technologies in healthcare and ICT sectors
- Potential for international scalability
- Commitment to sustainable growth
Portfolio Companies
Reach Defta Partners directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Defta Partners
What sectors does Defta Partners invest in?
Defta Partners invests in Healthcare, Telecommunications, Software, Medical Devices, Semiconductors and Biotechnology, and is based in United States. Defta Partners is listed as a venture capital in the ConnectSafely investor database.
What stage does Defta Partners invest at?
Defta Partners backs companies at Seed, Series A and Series B, writing cheques of 500K - 10M.
Which regions does Defta Partners invest in?
Defta Partners invests across United States, United Kingdom, Japan, Bangladesh and Israel.
Who are the partners at Defta Partners?
Team members listed for Defta Partners include Baldev Madahar (Chief Financial Officer) and Yuichi Kimura (Venture Partner).
What companies has Defta Partners invested in?
Defta Partners's portfolio includes Cambrian Biopharma, Aegle Therapeutics, Actuate Therapeutics, QuantuMDx, Acepodia, Anamne, bracNet and Actuate Corp.
How do I contact Defta Partners?
Defta Partners's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database